CTMC, a joint venture between Resilience and MD Anderson Cancer [...]

XenoSTART and Minerva Imaging have expanded their long-standing partnership to [...]

EG 427 has released encouraging first clinical data from its [...]

Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]

Levicept Ltd will present new findings from its Phase 2 [...]

Tevard Biosciences has presented new preclinical data demonstrating the potential [...]

SeaBeLife, a biotechnology company developing novel drug candidates to block [...]

Amorphical, developer of nano-amorphous mineral-based pharmacologic agents, has announced positive [...]

QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third [...]